Background

The Foreign-Trade Zones Board has recently announced the following actions. For more information on how FTZs can benefit your business, please contact attorney Lenny Feldman at (305) 894-1011 or via email.

- received a notification of proposed production activity at the Intel Corporation facility within FTZ 281 in Miami, Fla., which will be used for the kitting, assembly, and packaging of computer electronics (comments due by July 26)

- received a notification of proposed production activity at the Mercedes-Benz U.S. International Inc. facilities within FTZ 98 in Vance and Woodstock, Ala., where MBUSI already has authority to produce passenger motor vehicles, to add two finished products and various foreign-status materials and components to the scope of authority (comments due by July 27)

- approved production under zone procedures at the Enovix Corporation facility within FTZ 18 in Fremont, Calif., which is used for the production of lithium ion metal batteries

- approved production under zone procedures at the Celgene Corporation facilities within FTZ 49 in Warren and Summit, N.J., which are used for the production of cell therapy products

- approved production under zone procedures at the planned Eastman Chemical Company facility within FTZ 204 in Kingsport, Tenn., which will be used for methanolysis operations and the recycling of plastics

- approved production under zone procedures at the Juno Therapeutics Inc. facility within FTZ 5 in Bothell, Wash., which is used for the production of cell therapy products April 12)

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

Practice Areas

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.